NanoViricides Has Filed its Quarterly Report
Accesswire
*NV-387 Advancing to Phase II Clinical Trial for the Treatment of RSV Infection*
*SHELTON, CT / ACCESSWIRE / May 15,..
*NV-387 Advancing to Phase II Clinical Trial for the Treatment of RSV Infection*
*SHELTON, CT / ACCESSWIRE / May 15,..
· "Aiming to offer a Dengue antiviral treatment course in $100 price range"
· Hyundai Bioscience decides to conduct dengue..
*TORONTO, ON / ACCESSWIRE / April 10, 2024 / Jaguar Mining Inc. ("Jaguar" or the "Company") (TSX:JAG) *today announced preliminary..